儿童CKD 2至5D期矿物质代谢标志物的变化
该横断面研究纳入170例CKD 2至5D期患儿,分析10种CKD-MBD标志物的年龄及性别相关z评分。结果发现CKD 2期即出现sclerostin、总FGF23和AP升高,伴血磷和1,25(OH)2D3降低及维生素D缺乏/不足高发;从CKD 3A期起iFGF23和PTH逐渐升高、sKlotho降低;高磷血症和低钙血症仅见于CKD 4至5D期。
要点
- CKD 2期即可出现sclerostin、总FGF23和AP升高及血磷、1,25(OH)2D3降低。
- CKD 3A期起iFGF23和PTH逐渐升高,sKlotho降低。
- 高磷血症和低钙血症仅见于CKD 4至5D期。
核心结论
- CKD 2期即出现sclerostin、总FGF23和AP升高伴血磷和1,25(OH)2D3降低及维生素D缺乏/不足,是该儿科人群CKD-MBD最早标志物。
- 上述改变早于更严重CKD时PTH和iFGF23的平行指数增加及sKlotho降低。
研究设计与样本
- 横断面研究,纳入170例CKD 2至5D期儿童,分析10种CKD-MBD标志物的年龄及适用时的性别相关z评分。
主要发现
- CKD 2期血清sclerostin z评分0.97、总FGF23 z评分0.72、AP z评分0.61升高,血磷z评分-0.62、1,25(OH)2D3 z评分-0.80降低,维生素D缺乏或不足患病率80.3%。
- 从CKD 3A期起iFGF23 z评分0.49和PTH z评分1.68逐渐升高,sKlotho z评分-0.66降低。
- 高磷血症和低钙血症仅见于CKD 4至5D期患者。
- CKD-MBD标志物之间高度相关:sclerostin与总FGF23和eGFR相关;总FGF23与血磷、25(OH)D、转铁蛋白饱和度和iFGF23相关。
临床怎么用
- 在儿童CKD 2期即可评估sclerostin、总FGF23、AP、血磷和1,25(OH)2D3以早期识别CKD-MBD。
- 对CKD 3A期及以上患儿应关注iFGF23、PTH和sKlotho的变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Changes in age- and sex-related markers for chronic kidney disease (CKD)-mineral and bone disorder (MBD) (CKD-MBD) across CKD stages 2 to 5D have not yet been studied in children. METHODS: In this cross-sectional study, we investigated age, and where applicable, sex-related z-scores of 10 key markers for CKD-MBD in 170 children with stages 2-5D. RESULTS: We identified distinct CKD stage-dependent changes in CKD-MBD markers. In CKD stage 2, elevated serum sclerostin (z-score: 0.97), total fibroblast growth factor 23 (FGF23) (z-score: 0.72) and alkaline phosphatase (AP) (z-score: 0.61) concentrations were observed in association with reduced serum phosphate (z-score: -0.62) and 1,25-dihydroxy vitamin D3 (1,25(OH)2D3) (z-score: -0.80) and a high prevalence of vitamin D deficiency or insufficiency (80.3%). From CKD stage 3A onward, increasingly elevated levels of intact FGF23 (iFGF23) (z-score: 0.49), and parathyroid hormone (PTH) (z-score: 1.68) were observed, as well as reduced levels of soluble Klotho (sKlotho) (z-score: -0.66). In contrast, hyperphosphatemia and hypocalcemia were only noted in patients with CKD stages 4 to 5D. CKD-MBD markers were highly associated with each other, with sclerostin being associated with total FGF23 and estimated glomerular filtration rate (eGFR). Total FGF23 was associated with serum phosphate, 25-hydroxyvitamin D3 (25(OH)D), transferrin saturation, and iFGF23. CONCLUSION: Elevated sclerostin, total FGF23, and AP concentrations in combination with reduced serum phosphate and (1,25(OH)2D3) as well as vitamin deficiency or insufficiency were the earliest marker for CKD-MBD in this pediatric population and were present in CKD stage 2. This preceded the parallel exponential increase in PTH and iFGF23 and reduced sKlotho with more severe CKD in children.
引用
- Tschirner A, Weber H, Schermuly K, et al. Markers of Mineral Metabolism in Children With CKD Stages 2 to 5D. Kidney Int Rep. 2026. PMID: 41767622. doi:10.1016/j.ekir.2026.103800
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。